Guidelines for in vivo mouse models of myocardial infarction
Despite significant improvements in reperfusion strategies, acute coronary syndromes all too
often culminate in a myocardial infarction (MI). The consequent MI can, in turn, lead to …
often culminate in a myocardial infarction (MI). The consequent MI can, in turn, lead to …
Animal models to study cardiac arrhythmias
DJ Blackwell, J Schmeckpeper… - Circulation research, 2022 - Am Heart Assoc
Cardiac arrhythmias are a significant cause of morbidity and mortality worldwide, accounting
for 10% to 15% of all deaths. Although most arrhythmias are due to acquired heart disease …
for 10% to 15% of all deaths. Although most arrhythmias are due to acquired heart disease …
MicroRNA-210 controls mitochondrial metabolism and protects heart function in myocardial infarction
Background: Ischemic heart disease remains a leading cause of death worldwide. In this
study, we test the hypothesis that microRNA-210 protects the heart from myocardial …
study, we test the hypothesis that microRNA-210 protects the heart from myocardial …
4D physiologically adaptable cardiac patch: a 4-month in vivo study for the treatment of myocardial infarction
H Cui, C Liu, T Esworthy, Y Huang, Z Yu, X Zhou… - Science …, 2020 - science.org
There has been considerable progress in engineering cardiac scaffolds for the treatment of
myocardial infarction (MI). However, it is still challenging to replicate the structural specificity …
myocardial infarction (MI). However, it is still challenging to replicate the structural specificity …
Inhibition of lncRNA TUG1 upregulates miR-142-3p to ameliorate myocardial injury during ischemia and reperfusion via targeting HMGB1-and Rac1-induced …
Q Su, Y Liu, XW Lv, ZL Ye, YH Sun, BH Kong… - Journal of molecular and …, 2019 - Elsevier
Abstract Background Long non-coding RNAs (lncRNAs) play a central role in regulating
heart diseases. In the present study, we examined the effects of lncRNA taurine up …
heart diseases. In the present study, we examined the effects of lncRNA taurine up …
[HTML][HTML] ARC regulates programmed necrosis and myocardial ischemia/reperfusion injury through the inhibition of mPTP opening
T Xu, W Ding, X Ao, X Chu, Q Wan, Y Wang, D Xiao… - Redox Biology, 2019 - Elsevier
Necrosis is a key factor in myocardial injury during cardiac pathological processes, such as
myocardial infarction (MI), ischemia/reperfusion (I/R) injury and heart failure. Increasing …
myocardial infarction (MI), ischemia/reperfusion (I/R) injury and heart failure. Increasing …
Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research
V Rai, P Sharma, S Agrawal, DK Agrawal - Molecular and cellular …, 2017 - Springer
Heart disease causing cardiac cell death due to ischemia–reperfusion injury is a major
cause of morbidity and mortality in the United States. Coronary heart disease and …
cause of morbidity and mortality in the United States. Coronary heart disease and …
Cytochrome P450-derived eicosanoids and heart function
KL Jamieson, T Endo, AM Darwesh… - Pharmacology & …, 2017 - Elsevier
The cytochrome P450 monooxygenase system (CYP) is a multigene superfamily of
enzymes, which are important in the metabolism of foreign and endogenous compounds …
enzymes, which are important in the metabolism of foreign and endogenous compounds …
An engineered S1P chaperone attenuates hypertension and ischemic injury
Endothelial dysfunction, a hallmark of vascular disease, is restored by plasma high-density
lipoprotein (HDL). However, a generalized increase in HDL abundance is not beneficial …
lipoprotein (HDL). However, a generalized increase in HDL abundance is not beneficial …
Preclinical models of myocardial infarction: from mechanism to translation
TP Martin, EA MacDonald… - British Journal of …, 2022 - Wiley Online Library
Approximately 7 million people are affected by acute myocardial infarction (MI) each year,
and despite significant therapeutic and diagnostic advancements, MI remains a leading …
and despite significant therapeutic and diagnostic advancements, MI remains a leading …